GlassScriptPhysician profile
Juan C Mas
NPI 1942386768
$1,182.39
in general payments reported to CMS, 2019-2025
16 companies · $615 in 2025
The $615 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $160 · 2024: $264 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.23 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $490.97 | 2024-2025 | Dupixent |
| Smith+Nephew, INC. | $126.50 | 2022 | |
| Edwards Lifesciences Corporation | $116.98 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ars Pharmaceuticals Operations, INC. | $84.63 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $83.25 | 2023-2024 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $55.87 | 2022-2024 | Nucala |
| Novartis Pharmaceuticals Corporation | $51.79 | 2024-2025 | |
| Csl Behring | $37.00 | 2025 | Haegarda |
| Pfizer INC. | $20.23 | 2025 | |
| Lilly USA, LLC | $19.18 | 2024 | Ebglyss |
| Kaleo, INC. | $18.66 | 2024 | Auvi-Q |
| Alk-Abello, INC | $17.03 | 2025 | Odactra, Ragwitek, Grastek |
| Genzyme Corporation | $16.74 | 2024 | |
| Amgen INC. | $14.94 | 2025 | Tezspire |
| Grifols USA, LLC | $14.58 | 2025 | Xembify |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst US Sales Co., LLC | $14.04 | 2025 | Orladeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Mas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.